DR. TOBY SHAWE M.D. NPI 1851453765

NPI Details

DR. Toby Shawe, M.D. is a specialist in Wyndmoor, PA with 39 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Toby Shawe, M.D. NPI is 1851453765. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

910 E WILLOW GROVE AVE
WYNDMOOR, PA
ZIP 19038-910
Phone: (215) 836-7212
Fax: (215) 836-7715

The NPI 1851453765 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS:J7345)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Application of light by qualified health care professional to destroy precancer skin growth (HCPCS:96573)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• Shaving of skin growth of body, arms, or legs, more than 2.0 cm (HCPCS:11303)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection into skin growth, more than 7 growths (HCPCS:11901)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11306)
• Punch biopsy, first skin growth (HCPCS:11104)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11312)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 12/15/2006 and was last updated on 1/10/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.